TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer
Cellular Oncology · 2023-10 · 46 (5) · 1493-1507
DOI: 10.1007/s13402-023-00825-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 23.05.2023. Verfasst von Tian Zhong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, C…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Research Foundation from Sichuan Provincial Health and Family Planning Commission of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
- Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. tomsan2022@126.com.
- Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China. tomsan2022@126.com.
- Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China. lihongmin@med.uestc.edu.cn.
- Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. lihongmin@med.uestc.edu.cn.
Förderung
- Research Foundation from Sichuan Provincial Health and Family Planning Commission of China
Zitieren
APA
Zhong, T., Zhang, J., Liu, X., & Li, H. (2023). TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer. Cellular Oncology, 46(5), 1493-1507. https://doi.org/10.1007/s13402-023-00825-6
Vancouver
Zhong T, Zhang J, Liu X, Li H. TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer. Cellular Oncology. 2023;46(5):1493-1507. doi:10.1007/s13402-023-00825-6
BibTeX
@article{Zhong2023,
author = {Zhong, Tian and Zhang, Jing and Liu, Xingren and Li, Hongmin},
title = {TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer},
journal = {Cellular Oncology},
year = {2023},
volume = {46},
number = {5},
pages = {1493--1507},
doi = {10.1007/s13402-023-00825-6}
}
EUVIMED